Skip to main content

King Wealth

SEC CIK
0001568235
Latest filing
Aug 5, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by King Wealth, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q1 2022)
0
Sold out in Q1 2022
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q1 2021
Holdings of BMRN by King Wealth, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20220$00.0%−4,000−100.0%Sold outHolders
Q4 20214,000$353.0K0.1%−1,000−20.0%ReducedHolders
Q3 20215,000$386.0K0.1%00.0%UnchangedHolders
Q2 20215,000$417.0K0.1%00.0%UnchangedHolders
Q1 20215,000$378.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.